Why Did Flora Growth Corp (FLGC) Surge 6% In After-Hours Trading?

Benzinga
2025/12/12

Flora Growth Corp. (NASDAQ:FLGC) surged 5.98% to $10.55 in after-hours trading on Thursday.

Check out the current price of FLGC stock here.

According to Benzinga Pro data, the stock of the Florida-based company closed on Thursday at $9.96, up 3.59%.

Regulation A Filing

Flora Growth filed a Form 1-A with the SEC, an offering statement for Regulation A securities that are exempt from full registration.

The company is looking to sell up to 30 million common shares at $2.50 each, aiming to raise as much as $75 million in aggregate proceeds, according to SEC filings.

Aegis Capital Corp. is listed as a sales commission provider with fees of $5.25 million.

Legal fees total $250,000, with Dorsey & Whitney LLP and Kaufman & Canoles LLP serving as counsel.

See Also: Broadcom, Lululemon, Costco, RH, And Tilray: Why These 5 Stocks Are On Investors’ Radars Today

Financial Snapshot

The SEC filing disclosed cash and cash equivalents of $4.15 million. Total revenues reached $18.03 million against costs and expenses of $14.17 million.

The company reported a net loss of $3.4 million, with basic earnings per share of negative $0.38.

Flora Growth Corp also holds total assets of $24.27 million, total liabilities of $21.13 million, and stockholders' equity of $3.13 million.

The global pharmaceutical distributor and digital assets treasury company maintains 13.36 million common shares outstanding

Trading Metrics

The stock is down 85.25% over the past year.

Flora Growth Corp has a market capitalization of $7.43 million. Its annual trading range is $6.80 to $81.90.

Benzinga’s Edge Stock Rankings indicates FLGC stock has a negative price trend across all time frames. Track the performance of other players in this segment.

Read Next:

  • Costco Q1 Earnings: Revenue, EPS Top Estimates, Comparable Sales Climb 6.4%

Photo Courtesy: Gorodenkoff on Shutterstock.com

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10